Table 1.
Reason for Noncompliance With Guidelines
| AAD | Reason for Noncompliance With Guidelines | Number |
|---|---|---|
| Amiodarone | Prescribed to patients without CHF and/or LVH as first‐line therapy | 1455 |
| Dronedarone | Prescribed without guideline recommendation | 615 |
| Dofetilide | Prescribed to patients without CAD and/or CHF as first‐line therapy | 280 |
| Flecainide | Used in patients with CHF and/or CAD | 77 |
| Used in patients with LVH | 4 | |
| Propafenone | Used in patients with CHF and/or CAD | 94 |
| Used in patients with LVH | 1 | |
| Sotalol | Used in patients with decompensated CHF | 342 |
| Used in patients with LVH | 22 | |
| Disopyramide | Prescribed without guideline recommendation | 19 |
| Procainamide | Prescribed without guideline recommendation | 5 |
| Quinidine | Prescribed without guideline recommendation | 6 |
| Total | 2920 |
AAD indicates antiarrhythmic drug; CAD, coronary artery disease; CHF, congestive heart failure; LVH, left ventricular hypertrophy.